Sign In
Buy MGTX
$12.52
+0.310 (+2.54%)
At Close: Jul 21, 2026
MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares
07:47am, Thursday, 16'th Apr 2026
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the pricing of an und
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
07:10am, Thursday, 16'th Apr 2026
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that it has entered i
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced positive three-year d
MeiraGTx: Turning Dry Mouth Into Liquid Gold
01:26pm, Wednesday, 15'th Apr 2026
MeiraGTx is approaching a pivotal Phase 1 data readout for AAV-hAQP1 in radiation-induced xerostomia, with the stock recently hitting 52-week highs. MGTX's riboswitch-controlled gene therapy platform,
- Presentation to include 3-year data from all cohorts of the Phase 1 AQUAx Clinical Study - Cohort-level data and individual patient data from bilateral and unilateral cohorts will be presented for b
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength?
10:21am, Tuesday, 31'st Mar 2026
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
MeiraGTx Holdings plc (MGTX) Presents at RBC Capital Markets Virtual Ophthalmology Conference Transcript
04:45pm, Friday, 27'th Mar 2026
MeiraGTx Holdings plc (MGTX) Presents at RBC Capital Markets Virtual Ophthalmology Conference Transcript
Alexandria Forbes Sells 62,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock
04:22am, Friday, 27'th Mar 2026
MeiraGTx Holdings PLC (NASDAQ: MGTX - Get Free Report) CEO Alexandria Forbes sold 62,000 shares of the stock in a transaction that occurred on Tuesday, March 24th. The shares were sold at an average p
MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates
10:16am, Thursday, 26'th Mar 2026
MeiraGTx Holdings PLC (MGTX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.6 per share. This compares to a loss of $0.5 per share a year ago
FDA granted Breakthrough Therapy Designation for AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tract MeiraGTx to hol
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
04:28am, Monday, 16'th Mar 2026
Shares of MeiraGTx Holdings PLC (NASDAQ: MGTX - Get Free Report) have received an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, Marketbeat Ratings reports.
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of “Moderate Buy” from Analysts
03:29am, Thursday, 19'th Feb 2026
MeiraGTx Holdings PLC (NASDAQ: MGTX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the company, Marketbeat Ratings repo
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
08:00am, Tuesday, 03'rd Feb 2026
BOSTON, Feb. 3, 2026 /PRNewswire/ -- ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX), a v
AMH Equity Ltd Invests $658,000 in MeiraGTx Holdings PLC $MGTX
03:22am, Sunday, 18'th Jan 2026
AMH Equity Ltd acquired a new stake in shares of MeiraGTx Holdings PLC (NASDAQ: MGTX) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commissi
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of “Moderate Buy” by Analysts
01:26am, Wednesday, 31'st Dec 2025
MeiraGTx Holdings PLC (NASDAQ: MGTX - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the stock, MarketBeat reports. One
